Lista de obras - Federica Tomao - Dominio Público Uruguay

A 68-year-old Caucasian man presenting with urinary bladder lymphoepithelioma: a case report.

artículo científico publicado en 2013

A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer

artículo científico publicado en 2006

Adjuvant Therapy for Early Uterine High-Grade Leiomyosarcoma

scientific article published on 27 February 2019

An Update of Laparoscopy in Cervical Cancer Staging: Is It a Useful Procedure?

scientific article published on 29 August 2013

Angiogenesis and antiangiogenic agents in cervical cancer.

artículo científico publicado en 2014

Benign schwannoma in supraclavicular region: a false-positive lymph node recurrence of breast cancer suspected by PET scan

artículo científico publicado en 2014

Bevacizumab in Ovarian Cancer: State of the Art and Unanswered Questions

artículo científico publicado en 2016

Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer

artículo científico

Breast adenomyoepithelioma: a case report with malignant proliferation of epithelial and myoepithelial elements.

artículo científico publicado en 2013

Cervical cancer: are there potential new targets? An update on preclinical and clinical results.

artículo científico publicado en 2014

Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study

artículo científico publicado en 2014

Clinical use of fertility agents and risk of breast cancer: a recent update for an old problem.

artículo científico

Combination of bevacizumab and chemotherapy for platinum-resistant recurrent ovarian cancer: some observations about the AURELIA trial

scientific article published on 02 September 2014

Complete remission of cerebral endometriosis with dienogest: a case report

artículo científico publicado en 2018

Conization in Early Stage Cervical Cancer: Pattern of Recurrence in a 10-Year Single-Institution Experience.

artículo científico publicado en 2017

Correlation between fertility drugs use and malignant melanoma incidence: the state of the art.

artículo científico

Current status of bevacizumab in advanced ovarian cancer

artículo científico publicado en 2013

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

artículo científico publicado en 2019

Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study

artículo científico publicado en 2013

Emerging biological treatments for uterine cervical carcinoma.

artículo científico publicado en 2014

Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach

artículo científico publicado en 2013

Emerging role of pemetrexed in ovarian cancer

artículo científico publicado en 2009

Erratum to "Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study" - Tumori. 2014 Nov-Dec;100(6):e309-13

article

Etirinotecan pegol in women with recurrent platinum-resistant or refractory ovarian cancer

artículo científico publicado en 2019

Fertility and reproduction in breast cancer patients

scientific article published on 20 May 2020

Fertility drugs, reproductive strategies and ovarian cancer risk.

artículo científico publicado en 2014

First-Line Treatment with Olaparib for Early Stage BRCA-Positive Ovarian Cancer: May It Be Possible? Hypothesis Potentially Generating a Line of Research

scientific article published on 07 July 2020

GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer.

artículo científico publicado en 2017

Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients.

artículo científico publicado en 2013

Gonadotropin-releasing hormone agonists for the preservation of ovarian function during chemotherapy

artículo científico publicado en 2012

Hot flushes in women with breast cancer: state of the art and future perspectives

artículo científico

Immunogenicity of allo-vesicle carrying ERBB2 tumor antigen for dendritic cell-based anti-tumor immunotherapy.

artículo científico publicado en 2009

Immunologic treatments for precancerous lesions and uterine cervical cancer

artículo científico publicado en 2014

Immunotherapy For Ovarian Cancer: Recent Advances And Combination Therapeutic Approaches

artículo científico publicado en 2020

Impact of Hormone Receptor Status and Ki-67 Expression on Disease-Free Survival in Patients Affected by High-risk Endometrial Cancer.

artículo científico publicado en 2018

Impaired uterine artery flow associated with the presence of ovarian endometrioma: preliminary results of a prospective study.

artículo científico publicado en 2014

Improvement in progression-free survival in OCEANS bevacizumab arm: a critical point of view

artículo científico publicado en 2012

Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody

artículo científico publicado en 2014

Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: Old and Novel Questions

scientific article published on 25 September 2019

Intraperitoneal Chemotherapy: A Strategy for the Treatment of Refractory Ascites in Recurrent Endometrial Cancer Patients - Three Case Reports and Review of the Literature

scientific article published on 09 October 2019

Investigating molecular profiles of ovarian cancer: an update on cancer stem cells.

artículo científico

Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients?

artículo científico publicado en 2019

Is removing 9 lymph nodes a correct cutoff to define optimal lymphadenectomy?: The open question of lymph node count

artículo científico publicado en 2014

Metabolic Determinants and Anthropometric Indicators Impact Clinical-pathological Features in Epithelial Ovarian Cancer Patients.

artículo científico publicado en 2016

Metachronous and Synchronous Cancers in Patients with Neuroendocrine Tumors

scientific article published on 10 September 2019

Modified gluteal fold advancement V-Y flap for vulvar reconstruction after surgery for vulvar malignancies.

artículo científico publicado en 2013

Niraparib in ovarian cancer: results to date and clinical potential.

artículo científico publicado en 2017

Non-pegylated liposomal Doxorubicin-cyclophosphamide in sequential regimens with taxanes as neoadjuvant chemotherapy in breast cancer patients

artículo científico publicado en 2014

Overcoming platinum resistance in ovarian cancer treatment: from clinical practice to emerging chemical therapies.

artículo científico

Pembrolizumab in Programmed Death Ligand 1-Positive Endometrial Cancer

artículo científico publicado en 2017

Prognostic role of inguinal lymphadenectomy in vulvar squamous carcinoma: younger and older patients should be equally treated. A prospective study and literature review

artículo científico

Quality of Life Effects of Ovarian Suppression in the Suppression of Ovarian Function Trial

artículo científico publicado en 2016

Risk-reducing Salpingo-Oophorectomy in Women at Higher Risk of Ovarian and Breast Cancer: A Single Institution Prospective Series

artículo científico publicado en 2017

Sexual Health and Quality of Life Assessment among Ovarian Cancer Patients during Chemotherapy.

artículo científico publicado en 2016

Special issues in fertility preservation for gynecologic malignancies

artículo científico

Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review

artículo científico publicado en 2014

Targeting angiogenesis in endometrial cancer - new agents for tailored treatments.

artículo científico publicado en 2015

Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies

scientific article published on 11 April 2016

The EOLO (End-of-Life Ovarian Cancer) Study: Approach to Ovarian Cancer Patients at the End of Life

artículo científico publicado en 2019

The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients

scientific article published on 04 October 2018

The impact of CO2 laser for treatment of Bartholin's gland cyst or abscess on female sexual function: a pilot study

scientific article published on 22 August 2018

Thyroid dysfunction and tyrosine kinase inhibitors in renal cell carcinoma

artículo científico publicado en 2013

Triple-negative breast cancer: investigating potential molecular therapeutic target

artículo científico publicado en 2014

Triple-negative breast cancer: new perspectives for targeted therapies.

artículo científico publicado en 2015

Lista de obras de Federica Tomao

A 68-year-old Caucasian man presenting with urinary bladder lymphoepithelioma: a case report.

A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer

Adjuvant Therapy for Early Uterine High-Grade Leiomyosarcoma

An Update of Laparoscopy in Cervical Cancer Staging: Is It a Useful Procedure?

Angiogenesis and antiangiogenic agents in cervical cancer.

Benign schwannoma in supraclavicular region: a false-positive lymph node recurrence of breast cancer suspected by PET scan

Bevacizumab in Ovarian Cancer: State of the Art and Unanswered Questions

Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer

Breast adenomyoepithelioma: a case report with malignant proliferation of epithelial and myoepithelial elements.

Cervical cancer: are there potential new targets? An update on preclinical and clinical results.

Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study

Clinical use of fertility agents and risk of breast cancer: a recent update for an old problem.

Combination of bevacizumab and chemotherapy for platinum-resistant recurrent ovarian cancer: some observations about the AURELIA trial

Complete remission of cerebral endometriosis with dienogest: a case report

Conization in Early Stage Cervical Cancer: Pattern of Recurrence in a 10-Year Single-Institution Experience.

Correlation between fertility drugs use and malignant melanoma incidence: the state of the art.

Current status of bevacizumab in advanced ovarian cancer

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study

Emerging biological treatments for uterine cervical carcinoma.

Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach

Emerging role of pemetrexed in ovarian cancer

Erratum to "Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study" - Tumori. 2014 Nov-Dec;100(6):e309-13

Etirinotecan pegol in women with recurrent platinum-resistant or refractory ovarian cancer

Fertility and reproduction in breast cancer patients

Fertility drugs, reproductive strategies and ovarian cancer risk.

First-Line Treatment with Olaparib for Early Stage BRCA-Positive Ovarian Cancer: May It Be Possible? Hypothesis Potentially Generating a Line of Research

GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer.

Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients.

Gonadotropin-releasing hormone agonists for the preservation of ovarian function during chemotherapy

Hot flushes in women with breast cancer: state of the art and future perspectives

Immunogenicity of allo-vesicle carrying ERBB2 tumor antigen for dendritic cell-based anti-tumor immunotherapy.

Immunologic treatments for precancerous lesions and uterine cervical cancer

Immunotherapy For Ovarian Cancer: Recent Advances And Combination Therapeutic Approaches

Impact of Hormone Receptor Status and Ki-67 Expression on Disease-Free Survival in Patients Affected by High-risk Endometrial Cancer.

Impaired uterine artery flow associated with the presence of ovarian endometrioma: preliminary results of a prospective study.

Improvement in progression-free survival in OCEANS bevacizumab arm: a critical point of view

Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody

Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: Old and Novel Questions

Intraperitoneal Chemotherapy: A Strategy for the Treatment of Refractory Ascites in Recurrent Endometrial Cancer Patients - Three Case Reports and Review of the Literature

Investigating molecular profiles of ovarian cancer: an update on cancer stem cells.

Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients?

Is removing 9 lymph nodes a correct cutoff to define optimal lymphadenectomy?: The open question of lymph node count

Metabolic Determinants and Anthropometric Indicators Impact Clinical-pathological Features in Epithelial Ovarian Cancer Patients.

Metachronous and Synchronous Cancers in Patients with Neuroendocrine Tumors

Modified gluteal fold advancement V-Y flap for vulvar reconstruction after surgery for vulvar malignancies.

Niraparib in ovarian cancer: results to date and clinical potential.

Non-pegylated liposomal Doxorubicin-cyclophosphamide in sequential regimens with taxanes as neoadjuvant chemotherapy in breast cancer patients

Overcoming platinum resistance in ovarian cancer treatment: from clinical practice to emerging chemical therapies.

Pembrolizumab in Programmed Death Ligand 1-Positive Endometrial Cancer

Prognostic role of inguinal lymphadenectomy in vulvar squamous carcinoma: younger and older patients should be equally treated. A prospective study and literature review

Quality of Life Effects of Ovarian Suppression in the Suppression of Ovarian Function Trial

Risk-reducing Salpingo-Oophorectomy in Women at Higher Risk of Ovarian and Breast Cancer: A Single Institution Prospective Series

Sexual Health and Quality of Life Assessment among Ovarian Cancer Patients during Chemotherapy.

Special issues in fertility preservation for gynecologic malignancies

Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review

Targeting angiogenesis in endometrial cancer - new agents for tailored treatments.

Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies

The EOLO (End-of-Life Ovarian Cancer) Study: Approach to Ovarian Cancer Patients at the End of Life

The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients

The impact of CO2 laser for treatment of Bartholin's gland cyst or abscess on female sexual function: a pilot study

Thyroid dysfunction and tyrosine kinase inhibitors in renal cell carcinoma

Triple-negative breast cancer: investigating potential molecular therapeutic target

Triple-negative breast cancer: new perspectives for targeted therapies.